Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems

References

• Mansour JC, Chen H. Pancreatic endocrine tumors. J Surg Res 2004;120:139-61.
   PubMed Web of Science ®Google Scholar
• Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 2008;135:1469-92.
   PubMed Web of Science ®Google Scholar
• O'Grady HL, Conlon KC. Pancreatic neuroendocrine tumours. Eur J Surg Oncol 2008;34:324-32.
   PubMed Web of Science ®Google Scholar
• Schurr PG, Strate T, Rese K, Kaifi JT, Reichelt U, Petri S, Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience. Ann Surg 2007;245:273-81.
   PubMed Web of Science ®Google Scholar
• Hill JS, McPhee JT, McDade TP, Zhou Z, Sullivan ME, Whalen GF, Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer 2009;115:741-51.
   PubMed Web of Science ®Google Scholar
• Fendrich V, Langer P, Celik I, Bartsch DK, Zielke A, Ramaswamy A, An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg 2006;244:845-51.
   PubMed Web of Science ®Google Scholar
• Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 2005;19:753-81.
   PubMed Web of Science ®Google Scholar
• Solcia E, Rindi G, Paolotti D, La RS, Capella C, Fiocca R. Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract. Ann Oncol 1999;10(Suppl 2):S9-15.
   PubMedGoogle Scholar
• Capella C, Heitz PU, Hofler H, Solcia E, Kloppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 1995;425:547-60.
   PubMed Web of Science ®Google Scholar
• Rindi G, Kloppel G. Endocrine tumors of the gut and pancreas tumor biology and classification. Neuroendocrinology 2004;80(Suppl 1):12-5.
   PubMedGoogle Scholar
• Bilimoria KY, Bentrem DJ, Merkow RP, Tomlinson JS, Stewart AK, Ko CY, Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg 2007;205:558-63.
   PubMed Web of Science ®Google Scholar
• Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006;449:395-401.
   PubMed Web of Science ®Google Scholar
• Bettini R, Boninsegna L, Mantovani W, Capelli P, Bassi C, Pederzoli P, Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol 2008;19:903-8.
   PubMed Web of Science ®Google Scholar
• Ekeblad S, Skogseid B, Dunder K, Oberg K, Eriksson B. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res 2008;14:7798-803.
   PubMed Web of Science ®Google Scholar
• Bordi C, D'Adda T, Azzoni C, Pizzi S, Bottarelli L, Mormandi F, Criteria for malignancy in gastrointestinal endocrine tumors. Endocr Pathol 2006;17:119-29.
   PubMedGoogle Scholar
• Fischer L, Kleeff J, Esposito I, Hinz U, Zimmermann A, Friess H, Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 2008;95:627-35.
   PubMed Web of Science ®Google Scholar
• Phan GQ, Yeo CJ, Hruban RH, Littemoe KD, Pitt HA, Cameron JL. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: Review of 125 patients. J Gastrointest Surg 1998;2:473-82.
   PubMedGoogle Scholar
• Solorzano CC, Lee JE, Pisters PW, Vauthey JN, Ayers GD, Jean ME, Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery 2001;130:1078-85.
   PubMedGoogle Scholar
• You DD, Lee HG, Paik KY, Heo JS, Choi SH, Choi DW. The outcomes after surgical resection in pancreatic endocrine tumors: An institutional experience. Eur J Surg Oncol 2009;35:728-33.
   Google Scholar
• Bloomston M, Muscarella P, Shah MH, Frankel WL, Al-Saif O, Martin EW, Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreas. J Gastrointest Surg 2006;10:1361-70.
   PubMedGoogle Scholar
• Pelosi G, Bresaola E, Bogina G, Pasini F, Rodella S, Castelli P, Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol 1996;27:1124-34.
   PubMed Web of Science ®Google Scholar
• Lloyd RV. Utility of Ki-67 as a prognostic marker in pancreatic endocrine neoplasms. Am J Clin Pathol 1998;109:245-7.
   PubMedGoogle Scholar
• Rindi G, Capella C, Solcia E. Cell biology, clinicopathological profile, and classification of gastro-enteropancreatic endocrine tumors. J Mol Med 1998;76:413-20.
   PubMedGoogle Scholar
• Rigaud G, Missiaglia E, Moore PS, Zamboni G, Falconi M, Talamini G, High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res 2001;61:285-92.
   PubMed Web of Science ®Google Scholar
• Butturini G, Bettini R, Missiaglia E, Mantovani W, Dalai I, Capelli P, Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. Endocr Relat Cancer 2006;13:1213-21.
   PubMed Web of Science ®Google Scholar
• La RS, Rigoli E, Uccella S, Novario R, Capella C. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours. Histopathology 2007;50:597-606.
   PubMedGoogle Scholar
• Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 2005;12:1083-92.
   PubMed Web of Science ®Google Scholar
• Deschamps L, Handra-Luca A, O'Toole D, Sauvanet A, Ruszniewski P, Belghiti J, CD10 expression in pancreatic endocrine tumors: correlation with prognostic factors and survival. Hum Pathol 2006;37:802-8.
   PubMedGoogle Scholar
• Clarke MR, Baker EE, Weyant RJ, Hill L, Carty SE. Proliferative activity in pancreatic endocrine tumors: association with function, metastases, and survival. Endocr Pathol 1997;8:181-7.
   PubMedGoogle Scholar
• Jamali M, Chetty R. Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining. Endocr Pathol 2008;19:282-8.
   PubMed Web of Science ®Google Scholar
• Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redefining the R1 resection in pancreatic cancer. Br J Surg 2006;93:1232-7.
   PubMed Web of Science ®Google Scholar
• Westgaard A, Laronningen S, Mellem C, Eide TJ, Clausen OP, Moller B, Are survival predictions reliable? Hospital volume versus standardisation of histopathologic reporting for accuracy of survival estimates after pancreatoduodenectomy for adenocarcinoma. Eur J Cancer 2009;45:2850-9.
   Google Scholar